In this presentation, Dr. Deming reviews the evaluation and management of hepatocellular carcinoma (HCC) in patients with hepatitis C, including current treatment strategies and multidisciplinary care considerations. She discusses evidence-based… […]
Keyword: liver
Hepatocellular Carcinoma (HCC) in HCV: Screening and Surveillance | June 17, 2026
In this presentation, Dr. Deming reviews the screening and prevention guidelines for hepatocellular carcinoma (HCC), describes the recommendations for HCC screening and discusses the significance of on-going surveillance. […]
Read More… from Hepatocellular Carcinoma (HCC) in HCV: Screening and Surveillance | June 17, 2026
MASLD Management: Medications & Monitoring | June 12, 2025
In this presentation, Dr. Greenlee provides a comprehensive overview of medications and monitoring of MASLD (Metabolic dysfunction-Associated Steatotic Liver Disease), highlighting GLP-1/Dual RAs and pioglitazone for their liver and cardiovascular… […]
Read More… from MASLD Management: Medications & Monitoring | June 12, 2025
NASH Update 2024 | May 1, 2024
In this presentation, Dr. Richard Manch, MD, provides a comprehensive overview and update as it relates to Steatotic Liver Disease (SLD) and particularly, Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD).… […]
NASH Update 2023 | March 1, 2023
In this presentation, Dr. Richard Manch, MD, provides a comprehensive overview and update as it relates to Nonalcoholic Fatty Liver Disease (NAFLD) and particularly, Nonalcoholic Steatohepatitis (NASH). Furthermore, Dr. Manch… […]
Hepatitis B (HBV): The Basics | April 21, 2022
In this series of presentations, Dr. Jonathan Iralu, Chief Clinical Consultant for Infectious Diseases at IHS, provides a clinical update on emerging COVID-19 topics. Then, Dr. Karla Thornton, Professor in… […]
Read More… from Hepatitis B (HBV): The Basics | April 21, 2022
